Company: BACC
Filing Date: 2025-06-02
Form Type: S-1/A
Source: 0001185185-25-000574
Chunk: 367

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-06-02
Form: S-1/A
Chunk 367
---
 the Representative Shares are issued will agree) (i) to waive its redemption rights
(or right to participate in any tender offer) with respect to such shares in connection with the completion of the Company’s initial
Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account with respect to such shares
if the Company fails to complete a Business Combination within the Combination Period. In addition, the Representative Shares will not
be transferable, assignable or saleable until 30 days after the completion of our initial business combination (except with respect
to permitted transferees as described herein under the section of this prospectus entitled “Principal Shareholders — Restrictions on Transfers of Founder Shares and Private Placement Units”).

Note 8 — Shareholder’s Equity

Preference Shares— The Company is authorized to issue a total of 5,000,000 preference shares at par value of $0.0001 each. As of February 28, 2025, there were no preferred shares issued or outstanding.

Class A Ordinary Shares— The Company is authorized to issue a total of 500,000,000 Class A ordinary shares at par value of $0.0001 each. As of February 28, 2025 there were no Class A ordinary shares issued or outstanding.

Class B Ordinary Shares— The
Company is authorized to issue a total of 50,000,000 Class B ordinary shares at par value of $0.0001 each. On February 20, 2025,
the Sponsor made a capital contribution of $25,000, or approximately $0.004 per share, through payments of offering costs and expenses
on the Company’s behalf, for which the Company issued 6,059,925 Class B ordinary shares, known as founder shares, to the Sponsor.
In May 2025, the Company effected a share capitalization pursuant to which the Company issued an additional 1,009,988 founder shares
resulting in an aggregate of 7,069,913 founder shares outstanding to the Sponsor, resulting in a price per share of approximately $0.004
per share. Up to 922,163 of the founder shares may be surrendered by the Sponsor for no consideration depending on the extent to which
the underwriters’ over-allotment is exercised. All share and per-share amounts have been retroactively restated to reflect the
share capitalization. As of February 28, 2025, there were 7,069,913 Class B ordinary shares issued